Skip to main content

Structure Therapeutics Inc. (GPCR)

Sector
Pharmaceuticals
Last price
$18.17
As of

Kresmion compiles this page from GPCR's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Structure Therapeutics Inc. (GPCR): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-09.

As of . Source: SEC EDGAR filings for GPCR. Method and limitations.

COMPANY DOSSIER

See the full GPCR dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for GPCR on one page. Preview it with sample data, then open it live with a free account.

Preview the GPCR dossier

Active events for GPCR

FREE, NO ACCOUNT

Every event on GPCR, as it fires

You are seeing 5 of 8 events recorded on GPCR since 2026-05-30.

The five above landed across 3 days. The other 3 were recorded on 1 other days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, GPCR

More data on GPCR

GPCR against its peers

GPCR's return on equity of -9.3% ranks in the 50th percentile of 22 Pharmaceuticals sub-industry peers, fiscal periods ending between 2025-03-31 and 2026-06-30.

MetricGPCRPeer medianPercentilen
Revenue FYn/a431Mn/a20
Gross marginn/a73.3%n/a11
Operating marginn/a2.6%n/a19
Net marginn/a0.3%n/a20
Return on equity-9.3%-11.5%5022
P / En/a14.7xn/a9
1 year-49.1%11.1%624

Peers (25): PAHC, PCRX, NUVB, OCUL, INVA, NKTR, ANIP, SUPN, AMPH, OMER, ANRO, TRVI, HRMY, ESPR.D, COLL, ALMS, XERS, BHC, ACRS, OGN, TARS, AMLX, LQDA, AVIR, ACB. Fiscal periods ending between 2025-03-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (GPCR: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Cite this data

Kresmion counts the managers it follows that reported a non-option position in GPCR on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on GPCR in the last 180 days.

Upstream: SEC EDGAR filings for GPCR

Kresmion, "Structure Therapeutics Inc. (GPCR) institutional holdings and SEC filings", data as of 2026-11-17, https://kresmion.com/research/GPCR. Upstream data: SEC EDGAR filings for GPCR.

Link to this data (HTML):

<a href="https://kresmion.com/research/GPCR">Structure Therapeutics Inc. (GPCR) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow GPCR on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to GPCR for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the GPCR dossier
Share

The GPCR intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.